APA (7th ed.) Citation

Levine, J., Islam, R. K., Mo, L., Gulati, N., Adalsteinsson, J., Talia, J., . . . Ungar, B. (2025). Thromboembolism risk of Janus kinase inhibitors with concurrent oral contraceptive use: A global multicentre cohort study. Clinical & Experimental Dermatology, 50(8), 1682. https://doi.org/10.1093/ced/llaf178

Chicago Style (17th ed.) Citation

Levine, Jasmine, Rahib K. Islam, Lillian Mo, Nicholas Gulati, Jonas Adalsteinsson, Jordan Talia, Shari R. Lipner, and Benjamin Ungar. "Thromboembolism Risk of Janus Kinase Inhibitors with Concurrent Oral Contraceptive Use: A Global Multicentre Cohort Study." Clinical & Experimental Dermatology 50, no. 8 (2025): 1682. https://doi.org/10.1093/ced/llaf178.

MLA (9th ed.) Citation

Levine, Jasmine, et al. "Thromboembolism Risk of Janus Kinase Inhibitors with Concurrent Oral Contraceptive Use: A Global Multicentre Cohort Study." Clinical & Experimental Dermatology, vol. 50, no. 8, 2025, p. 1682, https://doi.org/10.1093/ced/llaf178.